Canaccord Genuity Starts Dimension Therapeutics (DMTX) at Buy

Go back to Canaccord Genuity Starts Dimension Therapeutics (DMTX) at Buy

Citi Starts Dimension Therapeutics (DMTX) at Buy

November 16, 2015 7:20 AM EST

Citi initiated coverage on Dimension Therapeutics (NASDAQ: DMTX) with a Buy rating and a price target of $18.00.

For an analyst ratings summary and ratings history on Dimension Therapeutics click here. For more ratings news on Dimension Therapeutics click here.

Shares of Dimension Therapeutics closed at $13.88 yesterday.

... More

Goldman Sachs Starts Dimension Therapeutics (DMTX) at Buy

November 16, 2015 7:20 AM EST

Goldman Sachs initiated coverage on Dimension Therapeutics (NASDAQ: DMTX) with a Buy rating and a price target of $20.00.

For an analyst ratings summary and ratings history on Dimension Therapeutics click here. For more ratings news on Dimension Therapeutics click here.

Shares of Dimension Therapeutics closed at $13.88 yesterday.

... More